Coronavirus News Roundup: Pfizer Releases More Data on COVID-19 Vaccine
Here’s a roundup of the latest coronavirus-related news.
Pfizer-BioNTech Releases Newest Topline Data for COVID-19 Vaccine
Pfizer and BioNTech announced topline results from an analysis spanning through March 13, which in part showed their COVID-19 vaccine to be 91.3% effective against the virus for up to 6 months after the second dose.
Pfizer-BioNTech COVID-19 Vaccine Shows High Efficacy in Adolescents
Pfizer/BioNTech has just released their topline data from their Phase 3 study of participants aged 12 to 15 years.
Analysis: The Effect of Remote Immunization Screenings on Vaccine Uptake
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
Moderna, Pfizer Vaccines Safe and Effective in Pregnant, Lactating Women
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
Prime Therapeutics Boosts COVID-19 Vax Administration Fees To Match What CMS Is Paying
The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
